Bioxytran (BIXT) Non-Current Assets (2010 - 2026)
Bioxytran (BIXT) reported Non-Current Assets of $156,009 for Q2 2026, up 8.1% from $144,357 a year earlier and up 2.5% from the prior quarter.
Powered by 
Analysis
Bioxytran (BIXT) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Bioxytran posted Non-Current Assets of $145,087, up 8.6% from FY2024.
- Non-Current Assets has increased for five consecutive years, with a five-year compound annual growth rate of 70.7% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $133,540 in FY2024 (+19.7%), $111,552 in FY2023 (+47.7%), $75,535 in FY2022 (+60.9%) and $46,932 in FY2021 (+369.3%).
- The Q2 2026 figure ranks as the highest quarterly Non-Current Assets since Q2 2018.
- Year over year, Non-Current Assets has now increased in each of the last 19 quarters, with growth averaging 15.0% over the last eight quarters.
- Over the past five years, the year-over-year growth in Non-Current Assets ranged from 8.1% (Q2 2026) to 369.3% (Q4 2021).
- Per Business Quant data, the three quarters before Q2 2026 came in at $152,206 (Q1 2026), $145,087 (Q4 2025) and $141,795 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - | 156,009.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 156,009.00 |
| Mar 31, 2026 | 152,206.00 |
| Dec 31, 2025 | 145,087.00 |
| Sep 30, 2025 | 141,795.00 |
| Jun 30, 2025 | 144,357.00 |
| Mar 31, 2025 | 131,704.00 |
| Dec 31, 2024 | 133,540.00 |
| Sep 30, 2024 | 124,336.00 |
| Jun 30, 2024 | 115,031.00 |
| Mar 31, 2024 | 115,516.00 |
| Dec 31, 2023 | 111,552.00 |
| Sep 30, 2023 | 108,770.00 |
| Jun 30, 2023 | 97,880.00 |
| Mar 31, 2023 | 79,732.00 |
| Dec 31, 2022 | 75,535.00 |
| Sep 30, 2022 | 74,349.00 |
| Jun 30, 2022 | 67,548.00 |
| Mar 31, 2022 | 68,343.00 |
| Dec 31, 2021 | 46,932.00 |
| Sep 30, 2021 | 18,954.00 |
API Access
Bioxytran Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();